Skip to content
Saturday, November 7, 2026
Pro Reel Arena

Zimbabwe Declines ‘Lopsided’ US Health Aid Agreement Over Data Concerns

Health aid image
The proposed American financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) spanning five years due to the United States' demand for confidential information.

This rejection was revealed after a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "unbalanced".

A government spokesman has since stated that the US was requesting biological samples for scientific study and profit but was unwilling to guarantee the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for continued dialogue to find a deal agreeable to both sides so the nation's critical HIV programme can continue.

Wider Context

This rejection follows a comparable case in Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the security of citizens' health data.

Since resuming office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.

As per statements, 16 African countries have so far signed similar health pacts, representing over $18.3bn in new funding.

Details of the Declined Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to provide its genetic material and health information over an extended period, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that could result from that shared data," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research with no assurance that the final treatments would be available to our citizens should a future disease outbreak emerge."

Sovereignty and Global Health

Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems previously established through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential pandemics.

"This system is designed to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how subsequent collaboration might be designed in a way that respects the independence and interests of both nations."

Health Experts Response

A leading public health body expressed it recognised the government's concerns, but urged that negotiations must proceed considering much of the nation's Aids initiatives depended on foreign aid.

"Where specific concerns exist, including those relating to information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it said.

This impasse underscores the ongoing tensions between receiving much-needed foreign assistance and safeguarding local interests in an ever more data-driven world.

The writer

Jessica Sanchez

Passionate angler and fishing gear expert with over 15 years of experience in freshwater and saltwater fishing.

Pro Reel Arena

Type to search articles.